#CHMP
women so meaty it maes me want to chmp them and cook their flab... uh- what? It DOES look delicious!

Peach for scale

#SpritoArt
November 12, 2026 at 9:07 PM
The CHMP has recommended expanding dolutegravir to term newborns weighing at least 2 kg and dolutegravir/lamivudine to children as young as 3 months, and European Commission decisions are expected in Q1 2027. #HIV #IDsky
www.contagionlive.com/view/chmp-re...
CHMP Recommends Dolutegravir, Dolutegravir/Lamivudine for Children With HIV | Contagion Live
The CHMP has recommended expanding dolutegravir to term newborns weighing at least 2 kg and dolutegravir/lamivudine to children as young as 3 months, and European Commission decisions are expected in ...
www.contagionlive.com
November 16, 2026 at 3:49 PM
EU: CHMP positive opinion for a new use of obinutuzumab (Gazyvaro). Gazyvaro is indicated as an add-on therapy for the treatment of adult patients with moderate to severe, active, autoantibody-positive systemic lupus erythematosus (SLE) despite standard therapy.
Obinutuzumab: CHMP opinion, new indication
In the regulator's own words, with the source. New medicines on Y (askwhy.science).
askwhy.science
November 17, 2026 at 4:15 PM
CHMP adopts prescriber advice: tirzepatide may reduce oral contraceptive reliability. https://www.mattheneus.com/editorial/ema-tirzepatide-oral-contraceptive-reliability-prescriber-communication-chmp-2026-11-12 #HTA #RegulatoryAffairs #Pharma
November 18, 2026 at 4:04 PM
EU: CHMP positive opinion for baxdrostat (Baxfendy). Treatment of hypertension in adults.
Baxdrostat: CHMP positive opinion
In the regulator's own words, with the source. New medicines on Y (askwhy.science).
askwhy.science
November 17, 2026 at 6:15 PM
EU: CHMP positive opinion for baxdrostat (Baxfendy). Treatment of hypertension in adults.
Baxdrostat: CHMP positive opinion
In the regulator's own words, with the source. New medicines on Y (askwhy.science).
askwhy.science
November 17, 2026 at 4:15 PM
CHMP recommends Baxfendy (baxdrostat) for uncontrolled hypertension. A recommendation, not an authorisation; Commission decision pending.
https://europepharmatoday.com/news/chmp-baxfendy-baxdrostat-hypertension-november-2026?utm_source=bluesky&utm_medium=social&utm_campaign=chmp-baxfendy
November 15, 2026 at 5:31 PM
EU: CHMP positive opinion for Aumolertinib (Aumseqa). Treatment of non-small cell lung cancer in adults.
Aumolertinib: CHMP positive opinion
In the regulator's own words, with the source. New medicines on Y (askwhy.science).
askwhy.science
November 17, 2026 at 8:15 PM
EU: CHMP positive opinion for sintilimab (Zybrivo). Treatment of non-squamous non-small cell lung cancer in adults.
Sintilimab: CHMP positive opinion
In the regulator's own words, with the source. New medicines on Y (askwhy.science).
askwhy.science
November 17, 2026 at 8:15 PM
📢 EMA's human medicines committee, the CHMP, recommended 7 new medicines for approval in the EU, including two medicines for lung cancer and two for diabetes. Read more here: 🔗 www.ema.europa.eu/en/news/meet... #PublicHealth #medsky 🧪 #SciComm
November 13, 2026 at 11:12 AM
CHMP positive opinion for aumolertinib in EGFR-mutated NSCLC: what the EU backing means for the evidence base heading into HTA. https://www.mattheneus.com/editorial/ema-aumseqa-aumolertinib-egfr-nsclc-positive-opinion-chmp-2026-11-12 #HTA #EvidenceSynthesis
November 17, 2026 at 9:08 AM
The CHMP of the EMA has issued a positive opinion recommending the marketing authorization of sintilimab plus pemetrexed and platinum-based chemotherapy for the first-line treatment of adult patients with nonsquamous NSCLC. #lcsm #oncology

www.onclive.com/view/sintili...
Sintilimab Receives Positive CHMP Opinion for First-Line Nonsquamous NSCLC | OncLive
The CHMP backed sintilimab plus chemotherapy in NSCLC; the FDA issued a complete response letter for the regimen in 2022.
www.onclive.com
November 18, 2026 at 1:00 AM
E ontem que terminou a reunião do CHMP e eu com mails com ações… 🫠
November 13, 2026 at 9:02 AM
[Union européenne] Sept nouveaux médicaments recommandés par le CHMP en novembre 2026

Le comité européen des médicaments pour l’homme a recommandé sept nouveaux…

https://infos.kanibal-studio.com/sept-nouveaux-medicaments-recommandes-par-le-chmp-en-novembre-2026-c4bd6c

#CHMP #Medicaments #Medecine
[Union européenne] Sept nouveaux médicaments recommandés par le CHMP en novembre 2026
Le comité européen des médicaments pour l’homme a recommandé sept nouveaux traitements lors de sa réunion de novembre 2026.
infos.kanibal-studio.com
November 14, 2026 at 8:12 PM
EU: CHMP positive opinion for a new use of secukinumab (Cosentyx). Adolescent hidradenitis suppurativa (HS) Cosentyx is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in adolescents 12 years and older with an inadequate response to…
Secukinumab: CHMP opinion, new indication
In the regulator's own words, with the source. New medicines on Y (askwhy.science).
askwhy.science
November 17, 2026 at 4:15 PM
Merck receives positive CHMP opinion to extend Enflonsia use to children up to 24 months

#Paediatrics
Merck receives positive CHMP opinion to extend Enflonsia use to children up to 24 months
Merck has received a positive EU CHMP opinion to expand the marketing authorisation for Enflonsia (clesrovimab) to children up to 24 months who remain vulnerable to severe RSV disease.
lungdaily.org
November 15, 2026 at 12:25 AM
The CHMP also recommended to extend the indication of 11 medicines, including one medicine for systemic lupus erythematosus: www.ema.europa.eu/en/news/ema-...
November 13, 2026 at 11:12 AM
$ZVRA NEWS Nov 13: Final negative CHMP opinion on arimoclomol in the EU.

Full story (not investment advice): https://www.merlintrader.com/zevra-therapeutics-stock-hub/
November 16, 2026 at 10:20 AM
FOR PISSCHAMP

CALL:
1-999-PIZ-CHMP
November 10, 2026 at 4:17 PM
November 10, 2026 at 4:22 PM
EMA authorisation of cemiplimab in first-line NSCLC sets a direct-comparator benchmark for checkpoint inhibitor submissions. https://www.mattheneus.com/editorial/ema-cemiplimab-libtayo-first-line-nsclc-dual-regimen-eu-authorisation-chmp-evidence-2026 #HTA #EvidenceSynthesis
November 17, 2026 at 9:08 AM
#$ZVRA shares fell after the CHMP adopted a negative opinion on arimoclomol for Niemann-Pick disease type C. European decision expected soon. notreload.xyz/xy/zevra-sha...
Zevra Shares Fall on Negative CHMP Opinion for Arimoclomol
Final European Commission decision pending.
notreload.xyz
November 13, 2026 at 12:27 PM
🟢 #$GSK — Regulatory Approval
Positive CHMP Opinion - Bexsero One-Dose MenB Booster
The EMA's CHMP recommended updating the Bexsero label to include a single booster dose for individuals aged 10 years and older previously vaccinated with Bexsero at least two yea…

https://biostock.app/symbols/GSK
November 13, 2026 at 1:55 PM